Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Holmberg

Showing results (191-200 of 287) with videos related to

Pageof 29
Sort By:
Plos One|February 4, 2021
Cumulative incidence of midline incisional hernia and its surgical treatment after radical cystectomy and urinary diversion for bladder cancer: A nation-wide population-based studyFredrik Liedberg, Oskar Hagberg, Firas Aljabery, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2012
Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS studyJennifer C Melvin, Divya Seth, Lars Holmberg, et al.
Frontiers in Oncology|April 17, 2025
Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish settingSanjib Saha, Ulf-Göran Gerdtham, Gottfrid Sjödahl, et al.
International Journal of Molecular Epidemiology and Genetics|December 4, 2012
Gamma-glutamyl transferase and C-reactive protein as alternative markers of metabolic abnormalities and their associated comorbidites: a prospective cohort studyJennifer C Melvin, Crystal Rodrigues, Lars Holmberg, et al.
Acta Oncologica (Stockholm, Sweden)|July 26, 2006
SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screeningStefan O Emdin, Bengt Granstrand, Anita Ringberg, et al.
BJU International|August 8, 2020
Treatment and prognosis of patients with urinary bladder cancer with other primary cancers: a nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe)Firas Aljabery, Fredrik Liedberg, Christel Häggström, et al.
The British Journal of Surgery|September 14, 2023
Angiosarcoma in the breast: a population-based cohort from SwedenSusanne Olander, Anna-Karin Wennstig, Hans Garmo, et al.
Nature Medicine|February 20, 2026
Colonoscopy and fecal immunochemical testing versus usual care in diagnostic colorectal cancer screening: the SCREESCO randomized controlled trialMarcus Westerberg, Jonas F Ludvigsson, Chris Metcalfe, et al.
Oncotarget|February 9, 2018
Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serumArunangshu Ghoshal, Hans Garmo, Rhonda Arthur, et al.
Plos One|February 2, 2013
Serum glucose and fructosamine in relation to risk of cancerWahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
Pageof 29

Showing results (191-200 of 287) with videos related to

Sort By:
Pageof 29
Plos One|February 4, 2021
Cumulative incidence of midline incisional hernia and its surgical treatment after radical cystectomy and urinary diversion for bladder cancer: A nation-wide population-based studyFredrik Liedberg, Oskar Hagberg, Firas Aljabery, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2012
Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS studyJennifer C Melvin, Divya Seth, Lars Holmberg, et al.
Frontiers in Oncology|April 17, 2025
Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish settingSanjib Saha, Ulf-Göran Gerdtham, Gottfrid Sjödahl, et al.
International Journal of Molecular Epidemiology and Genetics|December 4, 2012
Gamma-glutamyl transferase and C-reactive protein as alternative markers of metabolic abnormalities and their associated comorbidites: a prospective cohort studyJennifer C Melvin, Crystal Rodrigues, Lars Holmberg, et al.
Acta Oncologica (Stockholm, Sweden)|July 26, 2006
SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screeningStefan O Emdin, Bengt Granstrand, Anita Ringberg, et al.
BJU International|August 8, 2020
Treatment and prognosis of patients with urinary bladder cancer with other primary cancers: a nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe)Firas Aljabery, Fredrik Liedberg, Christel Häggström, et al.
The British Journal of Surgery|September 14, 2023
Angiosarcoma in the breast: a population-based cohort from SwedenSusanne Olander, Anna-Karin Wennstig, Hans Garmo, et al.
Nature Medicine|February 20, 2026
Colonoscopy and fecal immunochemical testing versus usual care in diagnostic colorectal cancer screening: the SCREESCO randomized controlled trialMarcus Westerberg, Jonas F Ludvigsson, Chris Metcalfe, et al.
Oncotarget|February 9, 2018
Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serumArunangshu Ghoshal, Hans Garmo, Rhonda Arthur, et al.
Plos One|February 2, 2013
Serum glucose and fructosamine in relation to risk of cancerWahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
Pageof 29